FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902165049> ?p ?o ?g. }

• W2902165049 endingPage "137.e1" @default.
• W2902165049 startingPage "129" @default.
• W2902165049 abstract "•Lipoprotein Insulin Resistance Index (LP-IR) is associated with insulin resistance. •Elevated LP-IR levels are associated with an increased type II diabetes mellitus risk. •LP-IR allowed to reclassify 27% of the patients from lower to higher type II diabetes mellitus risk. •LP-IR score ≥ 68 improved the Framingham Offspring prediction algorithm Background Early assessment of insulin resistance may be a way of identifying patients at risk as well as monitoring treatments that increase insulin sensitivity and reduce the risk of developing type II diabetes mellitus (T2DM). Objective The objective of the study was to evaluate the ability of the Lipoprotein Insulin Resistance Index (LP-IR) to predict incident T2DM in a large cohort. Methods LP-IR scores were calculated using 6 lipoprotein particle concentrations and sizes measured by nuclear magnetic resonance spectroscopy. In total, 5977 nondiabetic men and women were included. Cox proportional hazards regression was used to evaluate the association of LP-IR scores with incident T2DM. Results LP-IR scores were closely associated with insulin resistance, assessed by homeostatic model assessment of insulin resistance (r = 0.51; P < .0001). During a median follow-up for 7.5 years, 278 new T2DM cases were ascertained. The Kaplan–Meier plot with log-rank test (P < .001) demonstrated that elevated LP-IR levels are associated with an increased T2DM risk. In analyses adjusted for age and sex, LP-IR was associated with incident T2DM; hazard ratio (HR) for the highest versus lowest quartile was 10.18 (95% confidence interval: 6.24–16.61), P < .0001. After adjustment for clinical risk factors, the HR was attenuated but remained significant (HR 3.02 [1.73–5.25], P < .0001). LP-IR scores added significantly to the performance of the Framingham Offspring prediction algorithm; C-index (95% confidence interval) for the Framingham Offspring score without and with LP-IR (0.863 [0.863–0.864] and 0.868 [0.867–0.86], P < .0001). Similar results were observed when LP-IR was analyzed as a categorical variable with a clinical cut-point of 68. Conclusion LP-IR may be a convenient way to assess insulin resistance and T2DM risk, as well as to monitor preventative treatments. Early assessment of insulin resistance may be a way of identifying patients at risk as well as monitoring treatments that increase insulin sensitivity and reduce the risk of developing type II diabetes mellitus (T2DM). The objective of the study was to evaluate the ability of the Lipoprotein Insulin Resistance Index (LP-IR) to predict incident T2DM in a large cohort. LP-IR scores were calculated using 6 lipoprotein particle concentrations and sizes measured by nuclear magnetic resonance spectroscopy. In total, 5977 nondiabetic men and women were included. Cox proportional hazards regression was used to evaluate the association of LP-IR scores with incident T2DM. LP-IR scores were closely associated with insulin resistance, assessed by homeostatic model assessment of insulin resistance (r = 0.51; P < .0001). During a median follow-up for 7.5 years, 278 new T2DM cases were ascertained. The Kaplan–Meier plot with log-rank test (P < .001) demonstrated that elevated LP-IR levels are associated with an increased T2DM risk. In analyses adjusted for age and sex, LP-IR was associated with incident T2DM; hazard ratio (HR) for the highest versus lowest quartile was 10.18 (95% confidence interval: 6.24–16.61), P < .0001. After adjustment for clinical risk factors, the HR was attenuated but remained significant (HR 3.02 [1.73–5.25], P < .0001). LP-IR scores added significantly to the performance of the Framingham Offspring prediction algorithm; C-index (95% confidence interval) for the Framingham Offspring score without and with LP-IR (0.863 [0.863–0.864] and 0.868 [0.867–0.86], P < .0001). Similar results were observed when LP-IR was analyzed as a categorical variable with a clinical cut-point of 68. LP-IR may be a convenient way to assess insulin resistance and T2DM risk, as well as to monitor preventative treatments." @default.
• W2902165049 created "2018-12-11" @default.
• W2902165049 creator A5005538765 @default.
• W2902165049 creator A5006333805 @default.
• W2902165049 creator A5023220936 @default.
• W2902165049 creator A5038949732 @default.
• W2902165049 creator A5041851398 @default.
• W2902165049 creator A5062003423 @default.
• W2902165049 creator A5079626461 @default.
• W2902165049 date "2019-01-01" @default.
• W2902165049 modified "2023-10-18" @default.
• W2902165049 title "Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study" @default.
• W2902165049 cites W1984875752 @default.
• W2902165049 cites W1993119975 @default.
• W2902165049 cites W2022857939 @default.
• W2902165049 cites W2023797086 @default.
• W2902165049 cites W2029163015 @default.
• W2902165049 cites W2048325728 @default.
• W2902165049 cites W2074847887 @default.
• W2902165049 cites W2097474636 @default.
• W2902165049 cites W2099145104 @default.
• W2902165049 cites W2104159077 @default.
• W2902165049 cites W2113130966 @default.
• W2902165049 cites W2127459342 @default.
• W2902165049 cites W2129391866 @default.
• W2902165049 cites W2149822561 @default.
• W2902165049 cites W2156822292 @default.
• W2902165049 cites W2157135485 @default.
• W2902165049 cites W2158822657 @default.
• W2902165049 cites W2299421211 @default.
• W2902165049 cites W2342166197 @default.
• W2902165049 cites W2509820133 @default.
• W2902165049 cites W2547754839 @default.
• W2902165049 cites W2656848837 @default.
• W2902165049 cites W2802155106 @default.
• W2902165049 cites W2977629971 @default.
• W2902165049 doi "https://doi.org/10.1016/j.jacl.2018.11.009" @default.
• W2902165049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30591414" @default.
• W2902165049 hasPublicationYear "2019" @default.
• W2902165049 type Work @default.
• W2902165049 sameAs 2902165049 @default.
• W2902165049 citedByCount "29" @default.
• W2902165049 countsByYear W29021650492019 @default.
• W2902165049 countsByYear W29021650492020 @default.
• W2902165049 countsByYear W29021650492021 @default.
• W2902165049 countsByYear W29021650492022 @default.
• W2902165049 countsByYear W29021650492023 @default.
• W2902165049 crossrefType "journal-article" @default.
• W2902165049 hasAuthorship W2902165049A5005538765 @default.
• W2902165049 hasAuthorship W2902165049A5006333805 @default.
• W2902165049 hasAuthorship W2902165049A5023220936 @default.
• W2902165049 hasAuthorship W2902165049A5038949732 @default.
• W2902165049 hasAuthorship W2902165049A5041851398 @default.
• W2902165049 hasAuthorship W2902165049A5062003423 @default.
• W2902165049 hasAuthorship W2902165049A5079626461 @default.
• W2902165049 hasBestOaLocation W29021650492 @default.
• W2902165049 hasConcept C126322002 @default.
• W2902165049 hasConcept C134018914 @default.
• W2902165049 hasConcept C207103383 @default.
• W2902165049 hasConcept C2776104379 @default.
• W2902165049 hasConcept C2777180221 @default.
• W2902165049 hasConcept C2777391703 @default.
• W2902165049 hasConcept C2778163477 @default.
• W2902165049 hasConcept C2779306644 @default.
• W2902165049 hasConcept C2780072125 @default.
• W2902165049 hasConcept C2910068830 @default.
• W2902165049 hasConcept C2911022245 @default.
• W2902165049 hasConcept C44249647 @default.
• W2902165049 hasConcept C50382708 @default.
• W2902165049 hasConcept C555293320 @default.
• W2902165049 hasConcept C68443243 @default.
• W2902165049 hasConcept C71924100 @default.
• W2902165049 hasConcept C8243546 @default.
• W2902165049 hasConceptScore W2902165049C126322002 @default.
• W2902165049 hasConceptScore W2902165049C134018914 @default.
• W2902165049 hasConceptScore W2902165049C207103383 @default.
• W2902165049 hasConceptScore W2902165049C2776104379 @default.
• W2902165049 hasConceptScore W2902165049C2777180221 @default.
• W2902165049 hasConceptScore W2902165049C2777391703 @default.
• W2902165049 hasConceptScore W2902165049C2778163477 @default.
• W2902165049 hasConceptScore W2902165049C2779306644 @default.
• W2902165049 hasConceptScore W2902165049C2780072125 @default.
• W2902165049 hasConceptScore W2902165049C2910068830 @default.
• W2902165049 hasConceptScore W2902165049C2911022245 @default.
• W2902165049 hasConceptScore W2902165049C44249647 @default.
• W2902165049 hasConceptScore W2902165049C50382708 @default.
• W2902165049 hasConceptScore W2902165049C555293320 @default.
• W2902165049 hasConceptScore W2902165049C68443243 @default.
• W2902165049 hasConceptScore W2902165049C71924100 @default.
• W2902165049 hasConceptScore W2902165049C8243546 @default.
• W2902165049 hasFunder F4320335254 @default.
• W2902165049 hasIssue "1" @default.
• W2902165049 hasLocation W29021650491 @default.
• W2902165049 hasLocation W29021650492 @default.
• W2902165049 hasLocation W29021650493 @default.
• W2902165049 hasLocation W29021650494 @default.
• W2902165049 hasOpenAccess W2902165049 @default.
• W2902165049 hasPrimaryLocation W29021650491 @default.

• next